These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 27566329)

  • 1. Rheumatic Heart Disease in the Twenty-First Century.
    Woldu B; Bloomfield GS
    Curr Cardiol Rep; 2016 Oct; 18(10):96. PubMed ID: 27566329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seven key actions to eradicate rheumatic heart disease in Africa: the Addis Ababa communiqué.
    Watkins D; Zuhlke L; Engel M; Daniels R; Francis V; Shaboodien G; Kango M; Abul-Fadl A; Adeoye A; Ali S; Al-Kebsi M; Bode-Thomas F; Bukhman G; Damasceno A; Goshu DY; Elghamrawy A; Gitura B; Haileamlak A; Hailu A; Hugo-Hamman C; Justus S; Karthikeyan G; Kennedy N; Lwabi P; Mamo Y; Mntla P; Sutton C; Mocumbi AO; Mondo C; Mtaja A; Musuku J; Mucumbitsi J; Murango L; Nel G; Ogendo S; Ogola E; Ojji D; Olunuga TO; Redi MM; Rusingiza KE; Sani M; Sheta S; Shongwe S; van Dam J; Gamra H; Carapetis J; Lennon D; Mayosi BM
    Cardiovasc J Afr; 2016 May/Jun 23; 27(3):184-187. PubMed ID: 26815006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controlling acute rheumatic fever and rheumatic heart disease in developing countries: are we getting closer?
    de Dassel JL; Ralph AP; Carapetis JR
    Curr Opin Pediatr; 2015 Feb; 27(1):116-23. PubMed ID: 25490689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rheumatic heart disease: progress and challenges in India.
    Shah B; Sharma M; Kumar R; Brahmadathan KN; Abraham VJ; Tandon R
    Indian J Pediatr; 2013 Mar; 80 Suppl 1():S77-86. PubMed ID: 22941214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How accurate is the diagnosis of rheumatic fever in Egypt? Data from the national rheumatic heart disease prevention and control program (2006-2018).
    Ghamrawy A; Ibrahim NN; Abd El-Wahab EW
    PLoS Negl Trop Dis; 2020 Aug; 14(8):e0008558. PubMed ID: 32804953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Cost-Effectiveness Tool to Guide the Prioritization of Interventions for Rheumatic Fever and Rheumatic Heart Disease Control in African Nations.
    Watkins D; Lubinga SJ; Mayosi B; Babigumira JB
    PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004860. PubMed ID: 27512994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement in rheumatic fever and rheumatic heart disease management and prevention using a health centre-based continuous quality improvement approach.
    Ralph AP; Fittock M; Schultz R; Thompson D; Dowden M; Clemens T; Parnaby MG; Clark M; McDonald MI; Edwards KN; Carapetis JR; Bailie RS
    BMC Health Serv Res; 2013 Dec; 13():525. PubMed ID: 24350582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intramuscular versus enteral penicillin prophylaxis to prevent progression of rheumatic heart disease: Study protocol for a noninferiority randomized trial (the GOALIE trial).
    Rwebembera J; Ndagire E; Carvalho N; Webel AR; Sable C; Okello E; Sarnacki R; Spaziani AM; Mucunguzi A; Engelman D; Grobler A; Steer A; Beaton A
    Am Heart J; 2024 Sep; 275():74-85. PubMed ID: 38797460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute rheumatic fever and rheumatic heart disease--priorities in prevention, diagnosis and management. A report of the CSANZ Indigenous Cardiovascular Health Conference, Alice Springs 2011.
    Rémond MG; Wheaton GR; Walsh WF; Prior DL; Maguire GP
    Heart Lung Circ; 2012 Oct; 21(10):632-8. PubMed ID: 22726405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determining the impact of Benzathine penicillin G prophylaxis in children with latent rheumatic heart disease (GOAL trial): Study protocol for a randomized controlled trial.
    Beaton A; Okello E; Engelman D; Grobler A; Scheel A; DeWyer A; Sarnacki R; Omara IO; Rwebembera J; Sable C; Steer A
    Am Heart J; 2019 Sep; 215():95-105. PubMed ID: 31301533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute rheumatic fever and rheumatic heart disease.
    Carapetis JR; Beaton A; Cunningham MW; Guilherme L; Karthikeyan G; Mayosi BM; Sable C; Steer A; Wilson N; Wyber R; Zühlke L
    Nat Rev Dis Primers; 2016 Jan; 2():15084. PubMed ID: 27188830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 2020 Australian guideline for prevention, diagnosis and management of acute rheumatic fever and rheumatic heart disease.
    Ralph AP; Noonan S; Wade V; Currie BJ
    Med J Aust; 2021 Mar; 214(5):220-227. PubMed ID: 33190309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secondary prevention of rheumatic heart disease in Ethiopia: a multicenter study.
    Belay W; Dessie A; Ahmed H; Gedlu E; Mariyo A; Shehibo A; Tigabu Z; Aliyu MH; Soslow J
    BMC Cardiovasc Disord; 2022 Feb; 22(1):26. PubMed ID: 35109807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secondary prophylaxis to control rheumatic heart disease in developing countries: Put into a cage if can't be killed.
    Barik R
    Indian Heart J; 2018; 70(6):907-910. PubMed ID: 30580864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The WHF Roadmap for Reducing CV Morbidity and Mortality Through Prevention and Control of RHD.
    Palafox B; Mocumbi AO; Kumar RK; Ali SKM; Kennedy E; Haileamlak A; Watkins D; Petricca K; Wyber R; Timeon P; Mwangi J
    Glob Heart; 2017 Mar; 12(1):47-62. PubMed ID: 28336386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sharing success - understanding barriers and enablers to secondary prophylaxis delivery for rheumatic fever and rheumatic heart disease.
    Chamberlain-Salaun J; Mills J; Kevat PM; Rémond MG; Maguire GP
    BMC Cardiovasc Disord; 2016 Aug; 16(1):166. PubMed ID: 27581750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benzathine penicillin adherence for secondary prophylaxis among patients affected with rheumatic heart disease attending Mulago Hospital.
    Musoke C; Mondo CK; Okello E; Zhang W; Kakande B; Nyakoojo W; Freers J
    Cardiovasc J Afr; 2013 May; 24(4):124-9. PubMed ID: 24217043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adherence to secondary prevention of rheumatic fever and rheumatic heart disease in young people: an 11-year retrospective study.
    Liaw J; Gorton S; Heal C; White A
    Aust N Z J Public Health; 2022 Dec; 46(6):758-763. PubMed ID: 35616403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosing rheumatic heart disease: where are we now and what are the challenges?
    de Loizaga SR; Beaton AZ; Nascimento BR; Macedo FVB; Spolaor BCM; de Pádua LB; Ribeiro TFS; Oliveira GCF; Oliveira LR; de Almeida LFR; Moura TD; de Barros TT; Sable C; Nunes MCP
    Expert Rev Cardiovasc Ther; 2021 Sep; 19(9):777-786. PubMed ID: 34424119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Approaches to Improving Adherence to Secondary Prophylaxis for Rheumatic Fever and Rheumatic Heart Disease: A Literature Review with a Global Perspective.
    Rémond MG; Coyle ME; Mills JE; Maguire GP
    Cardiol Rev; 2016; 24(2):94-8. PubMed ID: 25807106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.